Fractyl Health, Inc. Common Stock
Fractyl Health, Inc. Common Stock（GUTS）股东结构
基于 13F 申报与流通股数据，展示机构、内部人与公众持股结构；下方为前十大机构、机构动向与内部人交易。
SEC 13F · FMP · GUTS · 截至 2025年9月30日
股东结构概览
74
机构持有人数
▲ 13 vs Q2
$145.55M
机构持仓总市值
▲ $100.69M vs Q2
72.19M
总流通股
freeFloat 40.70%
91.55M
13F 申报持股数
▲ 63.86M vs Q2
机构持仓% = 13F 持股数 ÷ 总流通股。内部人% = 100 − 自由流通率。散户% = 自由流通率 − 机构%。数据来源：FMP /symbol-positions-summary + /shares-float + SEC EDGAR。
前10大机构持仓
GUTS 最大股东 · 机构持仓
Q3 2025 · SEC 13F
显示前 10 家
| 机构 | 持股数 | 占比 | 权重 | 市值 | 申报日 | 变动 |
|---|---|---|---|---|---|---|
NANTAHALA CAPITAL MANAGEMENT, LLC surgical & medical instruments & apparatus | 12.14M | 18.77% | 18.77% | $19.30B | Nov 14, 2025 | NEW |
SILVERARC CAPITAL MANAGEMENT, LLC surgical & medical instruments & apparatus | 10.60M | 16.40% | 16.40% | $16.85B | Nov 12, 2025 | ▲ 10.40M |
ALYESKA INVESTMENT GROUP, L.P. surgical & medical instruments & apparatus | 5.65M | 8.74% | 8.74% | $8.98B | Nov 17, 2025 | NEW |
WOODLINE PARTNERS LP surgical & medical instruments & apparatus | 5.51M | 8.52% | 8.52% | $8.76B | Nov 14, 2025 | ▲ 4.91M |
CATALIO CAPITAL MANAGEMENT, LP surgical & medical instruments & apparatus | 5.21M | 8.06% | 8.06% | $8.29B | Nov 14, 2025 | ▲ 5.00M |
ROSALIND ADVISORS, INC. surgical & medical instruments & apparatus | 5.00M | 7.73% | 7.73% | $7.95B | Nov 13, 2025 | NEW |
GENERAL CATALYST GROUP MANAGEMENT, LLC surgical & medical instruments & apparatus | 4.88M | 7.55% | 7.55% | $7.77B | Nov 14, 2025 | — held |
DEER MANAGEMENT CO. LLC surgical & medical instruments & apparatus | 4.77M | 7.38% | 7.38% | $7.59B | Nov 14, 2025 | — held |
HCC MANAGER LLC surgical & medical instruments & apparatus | 4.67M | 7.23% | 7.23% | $7.43B | Nov 10, 2025 | — held |
683 CAPITAL MANAGEMENT, LLC surgical & medical instruments & apparatus | 4.65M | 7.19% | 7.19% | $7.39B | Nov 14, 2025 | ▲ 4.00M |
数据来源：SEC 13F 申报文件。变动标识：isNew / isSoldOut / changeInSharesNumber。
机构仓位变动
Q3 2025 对比上季度
Q3 2025
17
增持
+29.24M 股20
新建仓
首次建仓4
减持
−249.4K 股0
清仓
完全退出净股数变化（前50家）
+28.99M
+29.24M / −249.4K
净新增持仓人
+33
新建 20 个 / 退出 0 个
基于前50家最大机构持仓统计，全市场实际数量可能不同。
内幕交易买卖情绪
GUTS 内幕交易记录
数据来源：SEC Form 4
近期内部人员净买入。 卖出可能源于预定的 10b5-1 计划，不代表负面展望。
1
买入笔数
0
卖出笔数
0.00
买卖比
$0M
卖出总金额
最近内幕交易记录
最近10条 · 仅普通股
| 姓名 · 职位 | 日期 | 类型 | 股数 | 价格 | 金额 | 交易后持股 | 申报 |
|---|---|---|---|---|---|---|---|
Smith Weber Lara Chief Financial Officer | Jan 12, 2026 | Award | 1,036,800 | $2.00 | $2.07M | 1.04M | Form 4 ↗ |
Toomey Sarah General Counsel | Dec 15, 2025 | Award | 743,913 | $2.24 | $1.67M | 743.9K | Form 4 ↗ |
Caplan Jay David President, Chief Product Off. | Dec 15, 2025 | Award | 845,226 | $2.24 | $1.89M | 845.2K | Form 4 ↗ |
Rajagopalan Harith Chief Executive Officer | Dec 15, 2025 | Award | 2,486,302 | $2.24 | $5.57M | 2.49M | Form 4 ↗ |
Rajagopalan Harith Chief Executive Officer | Dec 4, 2025 | Purchase | 10,416 | $1.92 | $20.0K | 501.7K | Form 4 ↗ |
Thompson Christopher Charles director | Sep 2, 2025 | Award | 45,000 | $0.98 | $44.0K | 45.0K | Form 4 ↗ |
Sheffield Ian director | Sep 2, 2025 | Award | 45,000 | $0.98 | $44.0K | 45.0K | Form 4 ↗ |
SCHULMAN AMY W director | Jun 11, 2025 | Award | 22,500 | $2.27 | $51.1K | 22.5K | Form 4 ↗ |
Elia Marc director | Jun 11, 2025 | Award | 22,500 | $2.27 | $51.1K | 22.5K | Form 4 ↗ |
MEANWELL CLIVE director | Jun 11, 2025 | Award | 22,500 | $2.27 | $51.1K | 22.5K | Form 4 ↗ |
数据来源：SEC Form 4。买卖方向：acquisitionOrDisposition A=买入，D=卖出。已排除 RSU 归属（M-Exempt）。
关于机构与内部人持股结构
Fractyl Health, Inc. Common Stock（GUTS）主要由机构投资者持有，机构持股比例约为 100.0%。公司内部人员持股约 59.30%，散户及公众持股约占剩余的 0.00%。
Fractyl Health, Inc. Common Stock 最大机构股东为 NANTAHALA CAPITAL MANAGEMENT, LLC，截至 September 30, 2025 持有约 12.14 million 股，占总流通股的 18.77%。
目前共有 74 家机构持有 GUTS 股票，合计持仓市值约 $145,551,915，数据来源为最新 SEC 13F 申报。
常见问题
GUTS ownershipFractyl Health, Inc. Common Stock（GUTS）主要由机构投资者持有，机构持股约 100.0%。最大股东为 NANTAHALA CAPITAL MANAGEMENT, LLC，持股比例 18.77%。内部人员持股约 59.30%。数据来源 SEC Form 13F，截至 September 30, 2025。